3Centers for Disease Control and Prevention (CDC).Malignant mesothelioma mortality-United State,1999-2005[J].Morb Mortal Wkly Rep.2009,58(15):393-396. 被引量:1
4Bertazzi PA.Descriptive epidemiology of malignant mesotheliona[J].Med Lav,2005,96(4):287-303. 被引量:1
7Testa JR,Carbone M,Hirvonen A,et al.Loss of heterozygosity analysis defines a 3-cM region of 15q commonly deleted in human malignant mesothelioma[J].Cancer Res,1998,58:4505-4509. 被引量:1
8Bocchetta M,Di Resta I,Powers A,et al.Simian virus 40 and the human mesothelium[J].Proc Natl Acad Sci USA,2000,97:10214-10219. 被引量:1
9Procopio A,Strizzi L,Vianale G,et al.Enhanced expression of vascular endothelial growth factor (VEGF) plays a critical role in the tumor progression potential induced by simian virus 40 large T antigen[J].Genes Chromosomes Cancer,2000,29:173-179. 被引量:1
10Kane AB.Animal models of malignant mesothelioma[J].Inhal Toxicol,2006,18(12):1001-1004. 被引量:1
7[5]Derita VT,Hellman S,Rosenbeng SA,eds. Cancer,principles and practice of oncotogy[M]. 3rd. Philadetphia:Lippincott,1989:1399-1417 被引量:1
8[7]Humcharek M. Changing risk group for malignant mesothelioma[J]. Cancer,1992,69:2704 被引量:1
9Ruffle P, Feld R, Minkin S, et al. Diffuse malignant mesothelioma of the pleura in Ontario and Quebec:a respective study of 332 patients[J]. J Clin Oncol, 1989,7(8):1157. 被引量:1
10Ruseh VW, Piantadose S, Holmes EC. The role of extrapleural pneumonectomy in malignant pleural mesothelioma:a lung cancer study group trial[J]. J Thorae Cardiovasc Surg, 1991,102(1 ) : 1. 被引量:1
3Lee YC,Thompson RI,Andrew D, et al. Clinical and palliative care as- pects of malignantmesothelioma [ M ]. In : Robinson BWS, Chahinian AP(eds). Mesothelioma. London: Martin dunitz, 2002:111 -126. 被引量:1
4Edwards JG, Abrams KR, Leverment JN. Prognostic factors for ma- lignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems[ J]. Thorax, 2000, 55: 731. 被引量:1
5PisaniRJ, ColbyTV, W illiamsDE, eta. 1Malignantmesothelioma of the pleur[J]. Mayo Clin Proc, 1998, 63: 1234. 被引量:1